Procyta Tablet 100 mg (Sitagliptin Hydrochloride Hydrate)

Adult dose

This medication is administered once daily at a dose of 100 mg either alone or in combination therapy, with a maximum daily dose of 100 mg. In patients with moderate renal impairment (glomerular filtration rate [eGFR] 30 or more but less than 45), administer 50 mg once daily. In patients with severe renal impairment (glomerular filtration rate [eGFR] 15 or more but less than 30) or end-stage renal disease (ESRD), administer 25 mg once daily. This medication is

This medication may cause rare but serious allergic reactions, so if symptoms such as skin rash or difficulty breathing occur, stop taking it immediately and consult a doctor. During the use of this medication, inflammation of the pancreas, known as pancreatitis, may occur, so if symptoms such as severe abdominal pain or vomiting occur, inform the medical staff immediately. This medication should not be used by patients with type 1 diabetes or diabetic ketoacidosis, and it should not be taken by individuals who are allergic to this drug or any of its ingredients. Patients with impaired kidney function need to adjust the dosage of this medication and should undergo regular kidney function tests. While taking this medication, side effects such as cold symptoms, headache, dyspepsia, and diarrhea may occur, and particularly when taken with insulin or sulfonylureas, hypoglycemic symptoms may occur more frequently, so caution is advised. Symptoms of hypoglycemia include dizziness, trembling, and cold sweats, and it is important to consume sugar immediately and consult with medical staff if these symptoms occur. This medication is not recommended for pregnant or breastfeeding women, and its safety in children or adolescents under 18 years has not been established. Elderly patients may experience reduced kidney function, therefore dosage adjustments and monitoring of kidney function are necessary. In case of overdose, seek medical attention immediately, as this medication can be partially removed by hemodialysis. If symptoms such as joint pain or skin blisters occur during treatment, inform the doctor immediately and discontinue the medication if necessary. Due to the possibility of interactions with other medications, especially if taking insulin, sulfonylureas, cyclosporine, or digoxin, consult medical staff. While this medication does not have a significant impact on the cardiovascular system, it is still important to monitor cardiovascular symptoms during its use.

Serious side effects

Hives, severe swelling (angioedema), anaphylaxis, severe skin adverse reactions (including Stevens-Johnson syndrome), acute pancreatitis, liver abnormalities (elevated liver enzymes, risk of jaundice), severe and debilitating joint pain, blistering dermatitis, cardiac arrest, pneumonia, diabetic complications, metabolic acidosis, falls, severe edema, acute renal failure, rhabdomyolysis

Mild side effects

• Upper respiratory infection
• nasopharyngitis
• headache
• hypoglycemia
• diarrhea
• nausea
• constipation
• muscle pain
• limb pain
• back pain

This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and it is safe to store at room temperature between 1 and 30 degrees Celsius. Therefore, avoid excessively hot or cold places and keep it in an area that maintains an appropriate temperature.

Appearance

Bright brown, round, biconvex film-coated tablets

Package unit

28 tablets/box [14 tablets/PTP*2]